Company

Welcome to GSK Belgium

This year, GSK was awarded the "Factory of the Future" label, which rewards the efforts of employees who help keep GSK at the forefront of innovation and the move towards Industry 4.0 through pioneering digital and technological projects in the sector.

Factory of the Future 2024
30sec
Close Video

Our strategy

We make innovative vaccines and specialty medicines to prevent and treat disease. Our research and development focuses on the science of the immune system, human genetics and advanced technologies. Our research and development (R&D) focus is on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

GSK Belgium
9,000
employees on our 3 sites (Wavre, Rixensart, Gembloux).
Innovation and R&D
1 billion
€ invested in research and development in 2021.
Vaccines
21
candidate vaccines in R&D.

Ahead together

Innovation

group of children

Responsibility

Clinical trials

pinch icon

Bloodcells Anaemia illustration

Our global "Behind the science" magazine

Discover and read our latest innovations in our global "Behind the science" magazine.